In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. ACADIA Pharmaceuticals Inc ...

The founder of a "living room exhibition" that honours the Windrush generation has been praised for his volunteer work. Max ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.

Colin Farrell brought his rarely seen son Henry to the 2025 Emmy Awards. The actor, 49, and his look-alike son, 15, walked ...

Relmada Therapeutics ( ($RLMD) ) has shared an announcement. On September 17, 2025, Relmada Therapeutics updated its corporate presentation, ...

Foundation Announces $60K Scholarship Fund with Miami Dade College to Expand Opportunities for Young Adults with Disabilities as They Transition to Adulthood The Supreme Twins Foundation - a nonprofit ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Travere Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc.

Novo Nordisk inflicted much pain—and much-needed pain—when president and CEO Maziar (Mike) Doustdar announced the company’s ...

Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.

We all know that sitting for extended periods of time can negatively affect our health — but its role in weakening the muscles in your behind is a lesser known concern. "Dead butt syndrome", also ...

Rhonda Pacheco, who oversaw Zepbound’s launch, will run Takeda’s U.S. business. Elsewhere, early data suggested Maze might have a “best-in-class” rare disease drug and Arrowhead challenged Ionis in ...